Objective: The fenestrated Anaconda endograft (Vascutek/Terumo, Inchinnan, UK) is intended for the treatment of abdominal aortic aneurysms with an insufficient infrarenal landing zone. The endografts are custom-made with use of high-resolution, 1-mm-slice computed tomography angiography images. For every case, a nonsterile prototype and a three-dimensional (3D) model of the patient's aorta are constructed to allow the engineers as well as the physician to test-implant the device and to review the fit of the graft. The aim of this investigation was to assess the impact of 3D model construction and prototype testing on the design of the final sterile endograft.
Endovascular aneurysm repair (EVAR) offers reduced perioperative morbidity and mortality, and the ongoing improvement of graft design has reduced reintervention rates and improved long-term results. [1] [2] [3] [4] [5] Certain anatomic criteria exist for endovascular treatment of an abdominal aortic aneurysm, and up to 40% of patients may not be eligible for EVAR because of anatomic restrictions. [6] [7] [8] Proximal neck configuration is among the most important of concerns. Open aneurysm repair, hybrid procedures, parallel stent graft implantation, and fenestrated endovascular aortic repair (FEVAR) are alternative surgical options for treatment of aneurysms unsuitable for conventional EVAR because of their proximal neck configuration. [9] [10] [11] [12] Perioperative and midterm results of fenestrated graft implantation are encouraging, and a relatively new device, the fenestrated Anaconda endograft (Vascutek/ Terumo, Inchinnan, UK), has recently been introduced to the market. 7, 8, [13] [14] [15] The device is custom-made on the basis of high-resolution 1-mm-slice computed tomography (CT) angiography images. During the design process, a graft prototype and a three-dimensional (3D) model of the specific patient's anatomy are constructed for every case to allow in vitro visualization of the fit of the graft.
The role of such 3D models of anatomic structures for the preoperative setting has not been fully elucidated, and published studies are found from orthopedic and cardiothoracic surgery but not as much from a vascular or, more specifically, aortic surgery setting. [16] [17] [18] Studies exist on the value of patient-specific models in the informed consent process, but there is a paucity of data on the role of 3D models for prototype testing of custom-made endografts. 19 As the first published single-center experience on the impact of FEVAR prototype testing in rigid 3D aortic models, the current study therefore aimed to describe the process of aortic model construction from a technical standpoint and to report and assess the nature and extent of modifications to endograft design after prototype testing in a 3D aortic model.
METHODS
On review board approval, including a waiver of informed consent, data were collected for all patients who underwent treatment involving use of a custommade fenestrated Anaconda endograft at a single department of vascular and endovascular surgery. The study period spanned from April 1, 2013, to August 18, 2015.
As a standard procedure, Vascutek provides 3D models for all ordered fenestrated endografts to allow testing of a prototype of the custom-made graft. All 3D aortic models assessed in the current study were manufactured by stereolithography (SLA) printing, resulting in solid, rigid models. This type of printing involves the use of a liquid polymer resin, which is cured in layers by an ultraviolet laser programmed to follow a pattern based on specific input data. The printer reads the model detail from an SLA file derived from the Digital Imaging and Communications in Medicine (DICOM) data in a patient's CT scan (1-mm slices).
Scan data were processed by the commercially available software Mimics (Materialise, Leuven, Belgium) to allow the user to isolate the anatomic regions of interest held within the CT scan (segmentation process). The region of interest for included surgical cases involves the vascular structures and starts a few centimeters above the celiac trunk and expands over the visceral aortic segment, encapsulating any diseased or aneurysmal regions down to the aortic bifurcation. The initial segmentation represents blood flow, and if it were converted and 3D printed at this stage, it would result in a solid plastic lump representing the vessel lumen. The next step in manufacturing of the aortic models used in the current series, therefore, was to create a vessel wall on the outside of the blood flow segmentation. The initial segmentation could then be subtracted to leave a resultant representation of the "hollowed out" blood vessels. The final data set was eventually converted to an SLA file format, which was then sent directly to a 3D printer for aortic model creation.
Graft prototype test summaries and the surgeon's notes on the prototype testing process were reviewed.
Proximal seal as assessed by inspection of the sealing rings within the model after device deployment, position of fenestrations in relation to the respective ostium, and ease of branch cannulation with wires and advancement of sheaths into the target vessels as well as fabric alignment were the primary concerns during prototype testing (Fig 1) . In addition, the engineers subjectively assessed aortic angulation. An institutional log on FEVAR patients was completed with data from the engineers' prototype test results as well as the product request forms and the surgeon's notes. Technical success was defined as the ability to connect all target vessels (Fig 2 shows an example of an unconnected fenestration) and the absence of type I or type III endoleak. Outcome in terms of technical and clinical success was correlated to whether a change had been made to the final endograft design. Means and standard deviations are reported for continuous variables and frequencies and percentages for categorical variables. An independent samples t-test and a nonparametric equivalent, when applicable, were used to compare continuous variables among the study groups. A c 2 test as well as Fisher and mid-P exact tests were performed to compare categorical variables of the groups. Because of low expected values within the analyses, comparable P values reported are those from the mid-P exact test. Statistical analysis was performed using SPSS Statistics 16.0 (SPSS Inc, Chicago, Ill) and OpenEpi version 3.01 (Andrew G. Dean and Kevin M. Sullivan, Atlanta, Ga).
RESULTS
Sixty fenestrated Anaconda devices were implanted during the study period. The number of fenestrations per device ranged from one to five (mean, 2.9). On the basis of prototype testing, the engineers' reports mentioned theoretical concerns about the fit of the prosthesis in 51 cases (85% Recommendation: The authors suggest using the prototype of a custom-made endograft in a threedimensional model for fenestrated aortic aneurysm repair and modifying the device if needed before deployment.
included as comments rather than as actual concerns (standard text) due to specific design choices or anatomic features of the patient. They were not expected to adversely affect clinical outcome and therefore did not result in a recommendation to alter graft design. Modifications of graft design were, however, recommended by the engineers in 21 cases (35%). Among the most abundant of concerns by the engineers were those related to proximal sealing (Table I ). After prototype testing in the 3D aortic models by the surgeons, endograft design was eventually modified from the original prototype in 13 cases (22%) on the basis of the surgeons' instructions (Table II) . Because of extensive alterations to the design including addition of a fenestration in combination with a change of the graft diameter or a combination of added diameter-reducing pleats and a repositioning of two fenestrations, a second prototype was ordered in three cases.
The procedure was technically successful in 52 of 60 cases (87%). There was a significantly higher chance for technical success in cases with fewer than three fenestrations (risk for technical failure for two or fewer fenestrations, 0%; risk for technical failure with three or more fenestrations, 23%; P ¼ .01). In six patients, a total of seven target arteries remained unconnected. In the remaining two cases, a type III endoleak was seen on postoperative CT angiography (resolved through reintervention with ballooning of the affected stent grafts). In one patient with an unconnected fenestration, the left renal artery was connected successfully in the angiography suite within 24 hours after the primary procedure with no complications. This resulted in an assisted technical success rate of 92%. There was no statistically significant difference in technical success rate in comparing patients in whom the endograft had been modified after prototype testing (10 of 13 [77%]) with those in whom the final prosthesis remained unchanged from the initial prototype (42 of 47 [89%]; P ¼ .29 ; Table III ). Furthermore, in comparing clinical success for the two groups, defined as successful Example of an unconnected fenestration. The fenestration intended for the superior mesenteric artery (arrow) did not align with the target vessel ("eclipse phenomenon"). The target vessel was connected using a parallel graft (arrowhead).
exclusion of the aneurysm without any major adverse event, no statistically significant difference can be found (85% vs 92% success rate, respectively; P ¼ .50).
Failure to connect a fenestration resulted in one right nephrectomy, and three cases of unconnected accessory renal arteries resulted in partial renal infarction. Two unconnected celiac trunks remained asymptomatic. Unconnected fenestrations were not associated with postoperative endoleaks. The patient who required nephrectomy because of an unconnected renal fenestration experienced an increase in creatinine level from 1.7 mg/dL preoperatively to 2.2 mg/dL postoperatively.
DISCUSSION
The reliance of FEVAR on custom-made grafts has obvious implications for preoperative selection of patients and case planning. The waiting period associated with the planning and production processes limits usefulness of FEVAR in acute settings, and meticulous design of the graft is critical to achieving a high technical success rate and improving overall outcome. 20 A potential advantage of the Anaconda FEVAR device lies in the possibility of connecting all fenestrations to their respective aortic branches before complete deployment of the graft, whereas a controlled deployment system allows repositioning of the main body. Because this device has no supporting stents around the fenestrations, there is certain flexibility, allowing adaptation of the fenestration toward the respective target vessel ostium before final deployment of the main body. Although this offers technical advantages intraoperatively, the success of the procedure is heavily reliant on exact positioning of the fenestrations according to the applicable patient's anatomy. The inclusion of patient-specific anatomic 3D aortic models may therefore be useful to ensure an ideal anatomic fit. The models used in this cohort of patients are transparent, rigid, solid structures made of ultraviolet lightcured epoxy resin. Their being transparent can be considered a valuable property when the models are used for prototype testing because it allows visualization and evaluation of the deployed prototype inside the model. This allows verification that the custom-made device is indeed suitable for the specific patient for whom it has been designed. The position of any fenestrations relative to the target vessels can be evaluated and, if necessary, adjusted. Prototype deployment within the aortic model also allows visualization of the saddle shape that the proximal sealing rings will assume at the proximal sealing zone. Folds in the fabric that may appear in specific anatomies, potentially obstructing fenestration engagement, may also be assessed.
Limitations of this in vitro fit-test are the rigid design of the 3D model and the incapacity of prototype testing to account for intraoperative blood flow and its effect on configuration of the unsupported fabric of the endograft. For example, the rigid nature of the prototypes does not reliably simulate in vivo behavior of the proximal sealing rings. Thus, the engineers expressed concerns about proximal seal for a large number of patients, whereas no type I endoleaks were observed in the current series. This is a relevant finding to consider in assessing prototype fit in a rigid 3D aortic model. Also, the rigid nature of the model does not allow any conclusions about possible straightening of the aorta and iliac arteries caused by guidewires or delivery systems. Another limitation lies in the fact that the 3D models usually do not include the iliac and femoral arteries, which prohibits any information about the effect of applicable anatomy distal to the aortic bifurcation on in vivo positioning and configuration of the deployment device. Iliac arteries were initially included in the first prototypes but later omitted because most of them had to be sawed off to allow introduction of the delivery system. Also, the maximum length of printed segments with the 3D printer used is 20 cm. Therefore, for a majority of anatomies, the visceral segment cannot be printed in one piece along with the iliac arteries. Another limitation of the testing modality applied in the current series is that aortic angulation was assessed only subjectively, whereas this could easily be measured to allow objective comparisons. Less than one-quarter of all graft designs were eventually altered in the current series; however, as depicted in Table II , changes were not always limited to minor adjustments to the current design but resulted in a totally different FEVAR design (Fig 3; multiple major changes, a different graft size, or a different number of fenestrations) in 5% of patients (n ¼ 3). A new prototype was ordered in these cases because initial prototype testing was no longer considered to reliably represent the properties and fit of the planned endograft. Requesting a second prototype required an additional 1 to 2 weeks until delivery of a sterile device for implantation in the current series. The average time from case planning and acceptance until delivery of the final graft lies somewhere between 6 and 7 weeks. A "fast-track" service can be used to receive a sterile endograft within a minimum of 3 weeks. This, however, does not provide time for changes on the basis of results from prototype testing. In the current study, no ruptures during the waiting period for a custom-made graft were seen in any patients awaiting their FEVAR procedure at our department.
Clinical success in the current series is comparable with reports found in the current literature and well in line with a recent depiction of the learning curve with FEVAR. 21, 22 There was no statistically significant difference in technical success between procedures for which endograft design had been modified after prototype testing in a 3D aortic model and procedures in which no changes were made to the initial endograft design. This may indicate that at least in some cases, changes made on the basis of prototype testing in rigid 3D aortic models have contributed to achieving technical success even when initial assessment of the fit was not ideal. Unconnected fenestrations, however, occurred for both the patients with and the patients without modifications, emphasizing that an ideal fit of a prototype in a 3D aortic model is not necessarily a guarantee for technical success.
CONCLUSIONS
It is not an easy task to plan and to construct a fenestrated endograft for a complex aortic anatomy where exact positioning of the graft is paramount to guarantee cannulation of the aortic branches. The combination of a 3D model with the construction of a prototype enables the engineers as well as the surgeon to test-implant the device and to make necessary adjustments to the graft design. In the current series, >20% of graft designs were changed on the basis of prototype testing. Whereas an ideal in vitro fit of a prototype does not guarantee a perfect anatomic fit within the patient, we found prototype testing in 3D models to be a valuable tool during the design and preparation of our custom-made devices.
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